ANI Pharmaceuticals Inc
Затворен
СекторЗдравеопазване
82.22 -0.36
Преглед
Промяна на цената на акция
24 ч
Минимум
82.04
Максимум
83.9
Приходи | -61K 27M |
|---|---|
Продажби | -9.6M 237M |
P/E Средно за сектора | 20.609 50.958 |
EPS | 1.68 |
Марж на печалбата | 11.551 |
Служители | 970 |
EBITDA | -20M 57M |
Препоръки | Силна покупка |
|---|---|
12-месечна прогноза | +37.81% upside |
Следващи печалби | 7.08.2026 г. |
|---|
Пазарна капитализация | -41M 1.8B |
|---|---|
Предишно отваряне | 82.58 |
Предишно затваряне | 82.22 |
Настроения в новините
By Acuity
50%
50%
146 / 342 Класиране в Healthcare
ANI Pharmaceuticals Inc Графика
Миналото представяне не гарантира бъдещи резултати.
Относно ANI Pharmaceuticals Inc
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.